Details
Stereochemistry | RACEMIC |
Molecular Formula | C26H27ClN2.2ClH |
Molecular Weight | 475.881 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.Cl.ClC1=CC=C(C=C1)C(N2CCN(C\C=C\C3=CC=CC=C3)CC2)C4=CC=CC=C4
InChI
InChIKey=YFQRGPYJACKPRU-WRQJSNHTSA-N
InChI=1S/C26H27ClN2.2ClH/c27-25-15-13-24(14-16-25)26(23-11-5-2-6-12-23)29-20-18-28(19-21-29)17-7-10-22-8-3-1-4-9-22;;/h1-16,26H,17-21H2;2*1H/b10-7+;;
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C26H27ClN2 |
Molecular Weight | 402.959 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 1 |
Optical Activity | ( + / - ) |
Clocinizine is an antihistamine derivative of diphenylmethylpiperazine. Clocinizine is a competitive and reversible H1 receptor antagonist. The drug is marketed in Spain under tradename Senioral in combination with phenylpropanolamine for temporary relief of nasal congestion in colds, rhinitis, and sinusitis.
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:16:24 GMT 2023
by
admin
on
Fri Dec 15 17:16:24 GMT 2023
|
Record UNII |
AE8KM1QU3Q
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29578
Created by
admin on Fri Dec 15 17:16:24 GMT 2023 , Edited by admin on Fri Dec 15 17:16:24 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID70861847
Created by
admin on Fri Dec 15 17:16:24 GMT 2023 , Edited by admin on Fri Dec 15 17:16:24 GMT 2023
|
PRIMARY | |||
|
402584
Created by
admin on Fri Dec 15 17:16:24 GMT 2023 , Edited by admin on Fri Dec 15 17:16:24 GMT 2023
|
PRIMARY | RxNorm | ||
|
254-375-2
Created by
admin on Fri Dec 15 17:16:24 GMT 2023 , Edited by admin on Fri Dec 15 17:16:24 GMT 2023
|
PRIMARY | |||
|
100000087953
Created by
admin on Fri Dec 15 17:16:24 GMT 2023 , Edited by admin on Fri Dec 15 17:16:24 GMT 2023
|
PRIMARY | |||
|
AE8KM1QU3Q
Created by
admin on Fri Dec 15 17:16:24 GMT 2023 , Edited by admin on Fri Dec 15 17:16:24 GMT 2023
|
PRIMARY | |||
|
C97696
Created by
admin on Fri Dec 15 17:16:24 GMT 2023 , Edited by admin on Fri Dec 15 17:16:24 GMT 2023
|
PRIMARY | |||
|
39245-23-3
Created by
admin on Fri Dec 15 17:16:24 GMT 2023 , Edited by admin on Fri Dec 15 17:16:24 GMT 2023
|
PRIMARY | |||
|
SUB01350MIG
Created by
admin on Fri Dec 15 17:16:24 GMT 2023 , Edited by admin on Fri Dec 15 17:16:24 GMT 2023
|
PRIMARY | |||
|
6441604
Created by
admin on Fri Dec 15 17:16:24 GMT 2023 , Edited by admin on Fri Dec 15 17:16:24 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE | |||
|
ENANTIOMER -> RACEMATE | |||
|
ENANTIOMER -> RACEMATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |